BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

508 related articles for article (PubMed ID: 21115138)

  • 1. Acquired hemophilia a: diagnosis, aetiology, clinical spectrum and treatment options.
    Shetty S; Bhave M; Ghosh K
    Autoimmun Rev; 2011 Apr; 10(6):311-6. PubMed ID: 21115138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired haemophilia syndrome: pathophysiology and therapy.
    Elezović I
    Srp Arh Celok Lek; 2010 Jan; 138 Suppl 1():64-8. PubMed ID: 20229686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitor antibodies to factor VIII and factor IX: management.
    Lusher JM
    Semin Thromb Hemost; 2000; 26(2):179-88. PubMed ID: 10919411
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful immune tolerance induction with high-dose coagulation factor VIII and intravenous immunoglobulins in a patient with congenital hemophilia and high-titer inhibitor of coagulation factor VIII despite unfavorable prognosis for the therapy.
    Kubisz P; Plamenová I; Hollý P; Stasko J
    Med Sci Monit; 2009 Jun; 15(6):CS105-11. PubMed ID: 19488019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acquired hemophilia a: a current review of autoantibody disease.
    Sborov DW; Rodgers GM
    Clin Adv Hematol Oncol; 2012 Jan; 10(1):19-27. PubMed ID: 22398803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired hemophilia: a case report and review of the literature.
    Mulliez SM; Vantilborgh A; Devreese KM
    Int J Lab Hematol; 2014 Jun; 36(3):398-407. PubMed ID: 24750687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acquired hemophilia A.
    Franchini M
    Hematology; 2006 Apr; 11(2):119-25. PubMed ID: 16753853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired inhibitors of coagulation factors: part I-acquired hemophilia A.
    Coppola A; Favaloro EJ; Tufano A; Di Minno MN; Cerbone AM; Franchini M
    Semin Thromb Hemost; 2012 Jul; 38(5):433-46. PubMed ID: 22740182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acquired hemophilia caused by autoantibodies against factor VIII coagulation activity. Clinical, biological study and therapeutic indications. Experience based on a study of 9 cases].
    Liozon E; Delaire L; Turlure P; Jaccard A; Loustaud-Ratti V; Réméniéras L; Julia A; Gaillard S; Bordessoule D; Vidal E
    Ann Med Interne (Paris); 1997; 148(7):477-90. PubMed ID: 9538386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired haemophilia A].
    Brouwer RE; Huisman MV; Feuth JD; van der Meer FJ
    Ned Tijdschr Geneeskd; 1997 Jul; 141(27):1342-4. PubMed ID: 9380188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired hemophilia a in a patient with lumbar disc herniation: a case report and review of the literature.
    Li J; Shen H; Hou T; Li M; He S; Zhang H
    Spine (Phila Pa 1976); 2009 Apr; 34(8):E305-8. PubMed ID: 19365240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical heterogeneity of acquired hemophilia A: a description of 4 cases.
    Franchini M; Girelli D; Olivieri O; Bozzini C; Guiotto M; Zardini G; Lippi G; Manzato F; Gandin G
    Haematologica; 2005 Mar; 90(3):ECR16. PubMed ID: 15753057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired haemophilia: an overview for clinical practice.
    Kessler CM; Knöbl P
    Eur J Haematol; 2015 Dec; 95 Suppl 81():36-44. PubMed ID: 26679396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemophilia. Strategies for the treatment of inhibitor patients.
    Ingerslev J
    Haematologica; 2000 Oct; 85(10 Suppl):15-20. PubMed ID: 11187863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Challenges and open issues in the management of acquired hemophilia A (AHA).
    Shetty SD; Ghosh K
    Blood Cells Mol Dis; 2015 Mar; 54(3):275-80. PubMed ID: 25486929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia].
    Meili EO; Dazzi H; von Felten A
    Schweiz Med Wochenschr; 1995 Mar; 125(9):405-11. PubMed ID: 7892567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid decrease in high titer of factor VIII inhibitors upon immunosuppressive treatment in severe postpartum acquired hemophilia A.
    Pejsa V; Grgurević I; Kusec R; Gaćina P
    Croat Med J; 2004 Apr; 45(2):213-6. PubMed ID: 15103761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current management of acquired factor VIII inhibitors.
    Barnett B; Kruse-Jarres R; Leissinger CA
    Curr Opin Hematol; 2008 Sep; 15(5):451-5. PubMed ID: 18695367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acquired hemophilia.
    Bouvry P; Recloux P
    Haematologica; 1994; 79(6):550-6. PubMed ID: 7896216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.